Two Sigma Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,100
Closed -$228K 2582
2022
Q4
$228K Buy
7,100
+500
+8% +$17K ﹤0.01% 2148
2022
Q3
$236K Buy
+6,600
New +$274K ﹤0.01% 2149
2022
Q2
Sell
-19,600
Closed -$1.14M 2647
2022
Q1
$1.14M Sell
19,600
-22,200
-53% -$1.21M ﹤0.01% 1573
2021
Q4
$2.46M Sell
41,800
-36,300
-46% -$2.2M 0.01% 1091
2021
Q3
$4.74M Sell
78,100
-23,200
-23% -$1.36M 0.01% 811
2021
Q2
$6.08M Buy
101,300
+15,500
+18% +$777K 0.02% 776
2021
Q1
$4.05M Buy
85,800
+61,200
+249% +$2.52M 0.01% 939
2020
Q4
$925K Sell
24,600
-26,700
-52% -$880K ﹤0.01% 1597
2020
Q3
$1.68M Sell
51,300
-3,700
-7% -$157K ﹤0.01% 1257
2020
Q2
$2.49M Buy
55,000
+38,300
+229% +$1.96M 0.01% 1094
2020
Q1
$763K Sell
16,700
-53,800
-76% -$2.43M ﹤0.01% 1612
2019
Q4
$3.05M Sell
70,500
-44,900
-39% -$1.83M 0.01% 1039
2019
Q3
$4.18M Buy
+115,400
New +$4.86M 0.01% 829

Other funds holding ATEX

Two Sigma Advisers's ATEX Position: Q1 2023 in Review

Two Sigma Advisers sold out of Anterix (ATEX) in Q1 2023, closing a stake of 7,100 shares — an estimated $228K sold.

Two Sigma Advisers first reported a position in ATEX in Q3 2019 and held it in 13 quarters. The position peaked at $6.08M in Q2 2021. 88 funds tracked by Wall St. Rank hold ATEX as of Q1 2023.

  • Two Sigma Advisers reported no remaining Anterix position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 7,100 Anterix shares in Q1 2023, an estimated $228K.
  • Two Sigma Advisers first reported a position in Anterix in Q3 2019 and held it in 13 quarters.
  • Two Sigma Advisers's Anterix position peaked at $6.08M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Anterix as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.